Abstract P5-16-01: Implementation of routine genomic and proteomic profiling of metastatic breast cancer patients in a community cancer center
CB Williams(Avera Health), Brian Leyland‐Jones(Avera Health), Mascha Hoogeveen(Avera Health), Amy Krie(Amgen (United States)), Justin D. Klein(Nationwide Children's Hospital), Benjamin Solomon(Avera Health), KA Williams(Avera Health), P. De(Avera Health), Nandini Dey(University of South Dakota)
Cited by 0
Related Papers
Sensitive and specific multi-cancer detection and localization using methylation signatures in cell-free DNA
|Annals of Oncology|2020|1.5k
Molecular profiling of cancer patients enables personalized combination therapy: the I-PREDICT study
|Nature Medicine|2019|726
RET rearrangements are actionable alterations in breast cancer
|Nature Communications|2018|127
Assessment of Residual Cancer Burden and Event-Free Survival in Neoadjuvant Treatment for High-risk Breast Cancer
|JAMA Oncology|2021|110
Enrichment of PI3K-AKT–mTOR Pathway Activation in Hepatic Metastases from Breast Cancer
|Clinical Cancer Research|2017|97